What management is recommended for a patient with a left posterior central gyrus infarction three months ago causing global aphasia who now has increased oral drooling?

Management of Post-Stroke Drooling in a Patient with Global Aphasia

This patient requires immediate referral to speech-language pathology for oromotor therapy targeting drooling, which is the most effective non-surgical intervention, while continuing aphasia rehabilitation. 1, 2

Primary Management Approach

Speech-Language Therapy for Dual Concerns

• Oromotor therapy is the most useful non-surgical option for drooling management and should be initiated immediately as part of the comprehensive rehabilitation program. 2

• Speech-language therapy (SLT) for aphasia is strongly recommended (Class I, Level of Evidence A) and should continue despite the global aphasia diagnosis, as recovery is possible even in severe cases. 1, 3

• The patient should receive intensive SLT focusing on functional communication, as evidence supports effectiveness across all stages post-stroke, including chronic phases beyond 6 months. 1

Multidisciplinary Team Assessment

• A team approach is the key to successful rehabilitation for both drooling and aphasia management. 2

• The team should include speech-language pathologists, occupational therapists, and neurologists to address the interconnected issues of oral motor control and communication. 2

Drooling-Specific Interventions

Conservative Management (First-Line)

• Oromotor therapy targeting suprahyoid musculature and oral motor control should be the initial approach, as it addresses the underlying neuromuscular dysfunction without medication side effects. 2

• Behavioral therapy and biofeedback techniques can be incorporated into the rehabilitation program. 2

Pharmacological Options (Second-Line)

• Anticholinergic drugs are unsuitable for long-term use due to adverse effects causing serious medical complications or noncompliance, particularly problematic in stroke patients. 2

• Botulinum toxin A injection shows promise for drooling management, though optimal dosage, duration of action, and frequency of repeat injections remain undefined. 2

• Consider botulinum toxin A if conservative measures fail after 3-6 months of intensive therapy, recognizing it may not dramatically differ from oral antispasmodics in efficacy alone. 1

Surgical Consideration (Third-Line)

• Bilateral submandibular duct relocation with bilateral sublingual gland excision is the best available surgical option if conservative and pharmacological treatments fail. 2, 4

• This procedure showed 55% excellent outcomes and 40% good outcomes with mild, transient morbidity in long-term follow-up. 4

• Long-term results at 3.2 years post-operatively showed 84% of caregivers felt drooling had significantly reduced. 4

Aphasia Management Considerations

Behavioral Interventions

• Communication partner training is recommended (Class I, Level of Evidence B) and should involve family members and caregivers. 1

• Group treatment may be useful across the continuum of care, including community-based aphasia groups (Class IIb, Level of Evidence B). 1

• Computerized treatment may supplement therapy provided by a speech-language pathologist (Class IIb, Level of Evidence A). 1

Pharmacological Augmentation for Aphasia

• Donepezil shows significant improvement in aphasia quotient, repetition ability, naming ability, auditory comprehension, and oral expression in post-stroke aphasia. 5

• Memantine demonstrates improvement in aphasia quotient, naming ability, spontaneous speech, and repetition ability, though not in auditory comprehension. 5

• Consider pharmacological augmentation if language recovery plateaus after 3-6 months of intensive SLT, particularly donepezil given its favorable evidence profile. 5, 3

Critical Pitfalls to Avoid

• Do not assume global aphasia is untreatable – recovery is possible even in severe cases, and patients can shift from global aphasia to less severe forms (e.g., Wernicke's aphasia) with rehabilitation. 3, 6

• Do not delay drooling management – waiting allows social stigmatization and potential medical complications (aspiration, skin breakdown, dehydration) to develop. 2

• Do not use anticholinergic medications long-term for drooling without careful monitoring, as they cause serious complications in stroke patients. 2

• Do not separate drooling and aphasia management – both reflect oral-motor dysfunction and benefit from integrated speech-language pathology intervention. 1, 2

Monitoring and Follow-Up

• Assess drooling severity and frequency at each therapy session using standardized measures. 2, 4

• Re-evaluate aphasia severity using validated tools (e.g., Concise Chinese Aphasia Test or Western Aphasia Battery) every 3 months. 6

• If no improvement in drooling after 3-6 months of intensive oromotor therapy, escalate to botulinum toxin A or surgical consultation. 2, 4